We create and implement innovations based on bacteriophages
Micromir today
Since 2011, RPC "Micromir" has been studying bacteriophages and creating products based on them that are used in medicine, veterinary medicine and agriculture.
During this time, we have assembled a team of 120 highly qualified professionals, including production workers and researchers, organized full-cycle production using the latest equipment, and gathered our own collection of more than 1000 bacteriophages.
We promote phage therapy as an eco-friendly way to fight dangerous microorganisms, support the microbiome, and protect human and animal health.
Compose "phage cocktails" for the specific needs of the patient, institution, farm
Regularly update the composition of products to maintain their high efficiency
Laboratory
Develop new products based on bacteriophages
Research Building
Scientific base
The professionalism of our researchers helps to solve important problems:
Since 2011, we have been gathering our own collection of bacteriophages and host bacteria. Now it has:
While many phage researchers limit themselves to the framework of fundamental issues, RPC Micromir actively cooperates with those who work "in the field" — practicing doctors and veterinarians.
We see the urgent needs of practitioners and work to offer effective solutions.
More than 1000
virulent phages
More than 4500
host bacteria
Developing fundamental science
We are always happy to welcome like-minded people and are open to cooperation with laboratories, scientific institutions, and research teams.
Study of phage dosing through SUB systems for companion animals
Clinical approbation of a phage cocktail for the prevention of intestinal infections in sows and piglets before weaning (in cooperation with RusAgro)
Development of a tool for biological decontamination of seed material in pig and cattle breeding
To work out a method for dispensing preparations based on bacteriophages through SUB systems.
To work out a group method of phage-based drug dispensing through a drinking system, to confirm the clinical efficacy obtained during the pilot study.
To develop a tool and work out methods for introducing bacteriophages into seed material for decontamination from bacterial colonization.
Name
Purpose
№
Federal Center for Animal Health
Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Scientific institution
№
Federal Research Center "Fundamentals of Biotechnology" of the Russian Academy of Sciences
Federal Scientific and Clinical Center for Resuscitation and Rehabilitation
First St. Petersburg State Medical University named after Academician I.P. Pavlov
Moscow Research Institute of Epidemiology and Microbiology
Comparison of the effectiveness of a complex of bacteriophages with antibacterial drugs in growing broiler chickens in real production conditions
Poultry. 2023
International Journal of Molecular Sciences, 2024
Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic E. coli Strain
Название
Издание
Ссылка
№
Antibiotics. 2023.
Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series
Sci Rep. 2023.
Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms
Viruses. 2022.
Bacteriophage Cocktails in the Post-COVID Rehabilitation
Virol J. 2021.
Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation
The essence of this approach is to select a "phage cocktail" not for a single patient, but for an entire medical institution, department, farm, taking into account the circulating strains of bacteria.
Learn more about the features and benefits of adaptive phage therapy:
Adaptive phage therapy — a new direction in the use of bacteriophages
Production
Among Russian companies producing products with bacteriophages, our production building was the first to be certified according to GMP standards in 2019.
This confirms the highest standards of quality and safety.
Together with our partners, we can create a product for your needs from the substance to the finished product.
solution in a vial of 100 ml (one dose)
Direction:
Prevention and treatment of bacterial infections of the uterus (endometritis) in cows
Phagouterin
solution in a vial of 1000 ml
Direction:
Prevention and treatment of avian infections
Phagovet
Micromir today
Bacteriophages specific to Proteus vulgaris
Bacteriophages specific to Proteus mirabilis
Bacteriophages specific to Acinetobacter baumannii
Bacteriophages specific to Staphylococcus aureus
Bacteriophages specific to Escherichia coli
Bacteriophages specific to Pseudomonas aeruginosa
Bacteriophages specific to Enterococcus faecium
Bacteriophages specific to Staphylococcus epidermidis
Bacteriophages specific to Klebsiella
pneumoniae
solution in a vial of 100 ml (one dose)
Direction:
Prevention and treatment of bacterial infections of the uterus (endometritis) in cows
Phagouterin
solution in a vial of 1000 ml
Direction:
Prevention and treatment of avian infections
Phagovet
Micromir today
Bacteriophages specific to Klebsiella
pneumoniae
Bacteriophages specific to Enterococcus faecium
Bacteriophages specific to Pseudomonas aeruginosa
Bacteriophages specific to Escherichia coli
Bacteriophages specific to Staphylococcus aureus
Bacteriophages specific to Acinetobacter baumannii
Bacteriophages specific to Staphylococcus epidermidis
Bacteriophages specific to Proteus mirabilis
Bacteriophages specific to Proteus vulgaris
Лицензии
© RPC "Micromir" - an eco-friendly approach to microbiome regulation
Navigation
Products
By using this site, you consent to the use of cookies to help us make it more convenient for you. Read our personal data processing policy
OK
Реквизиты ООО НПЦ «МикроМир»
Адрес: 107031, г. Москва, Кисельный Нижний пер., д. 5/23, стр. 1
Генеральный Директор: Зурабов Георгий Александрович
Расчётный счёт
Филиал «Центральный» Банка ВТБ (ПАО) в г. Москве
Р/c: 40702810400000154785
К/c: 30101810145250000411
БИК: 044525411
ИНН: 7702649180
КПП: 770201001
Генеральный Директор: Зурабов Георгий Александрович
Расчётный счёт
Филиал «Центральный» Банка ВТБ (ПАО) в г. Москве
Р/c: 40702810400000154785
К/c: 30101810145250000411
БИК: 044525411
ИНН: 7702649180
КПП: 770201001